Skip to main content
Erschienen in: Journal of Anesthesia 3/2015

01.06.2015 | Short Communication

Dexmedetomidine and ketamine combination for a patient with xeroderma pigmentosa

verfasst von: Rakhee Goyal, Mubashir Syed Islam

Erschienen in: Journal of Anesthesia | Ausgabe 3/2015

Einloggen, um Zugang zu erhalten

Abstract

Patients of xeroderma pigmentosa (XP) have increased sensitivity to ultraviolet light and a defective nucleotide excision repair (NER) mechanism in their DNA. Several types of neurological, dermatological, and ophthalmological complications are common in these patients. There is increasing evidence of delayed recovery and worsening of neurological status following general anesthesia in such patients. Some reports have shown uneventful conduct of total intravenous anesthesia in patients of XP. The authors report a case of XP in a young girl for surgery, previously anesthetized with delayed recovery, managed successfully with a combination of intravenous dexmedetomidine and ketamine.
Literatur
1.
Zurück zum Zitat Masuda Y, Imaizumi H, Okanuma M, Narimatsu E, Asai Y, Namiki A. Anesthesia for a patient with xeroderma pigmentosum. Masui. 2002;51:169–71.PubMed Masuda Y, Imaizumi H, Okanuma M, Narimatsu E, Asai Y, Namiki A. Anesthesia for a patient with xeroderma pigmentosum. Masui. 2002;51:169–71.PubMed
2.
Zurück zum Zitat Fjouji S, Bensghir M, Yafat B, Bouhabba N, Boutayeb E, Azendour H, Kamili ND. Postoperative neurological aggravation after anesthesia with sevoflurane in a patient with xeroderma pigmentosum: a case report. J Med Case Rep. 2013;7:73.PubMedCentralPubMedCrossRef Fjouji S, Bensghir M, Yafat B, Bouhabba N, Boutayeb E, Azendour H, Kamili ND. Postoperative neurological aggravation after anesthesia with sevoflurane in a patient with xeroderma pigmentosum: a case report. J Med Case Rep. 2013;7:73.PubMedCentralPubMedCrossRef
3.
Zurück zum Zitat Miyazaki R, Nagata T, Kai T, Takahashi S. Anesthesia for a patient with xeroderma pigmentosum. Masui. 2007;56:439–41.PubMed Miyazaki R, Nagata T, Kai T, Takahashi S. Anesthesia for a patient with xeroderma pigmentosum. Masui. 2007;56:439–41.PubMed
4.
Zurück zum Zitat Kraemer KH, Lee MM, Scotto J. Xeroderma pigmentosum. Cutaneous, ocular, and neurologic abnormalities in 830 published cases. Arch Dermatol. 1987;123:241–50.PubMedCrossRef Kraemer KH, Lee MM, Scotto J. Xeroderma pigmentosum. Cutaneous, ocular, and neurologic abnormalities in 830 published cases. Arch Dermatol. 1987;123:241–50.PubMedCrossRef
5.
Zurück zum Zitat Brooks PJ. The 8,5′-cyclopurine-2′-deoxynucleosides: candidate neurodegenerative DNA lesions in xeroderma pigmentosum, and unique probes of transcription and nucleotide excision repair. DNA Repair (Amst). 2008;7:1168–79.CrossRef Brooks PJ. The 8,5′-cyclopurine-2′-deoxynucleosides: candidate neurodegenerative DNA lesions in xeroderma pigmentosum, and unique probes of transcription and nucleotide excision repair. DNA Repair (Amst). 2008;7:1168–79.CrossRef
6.
Zurück zum Zitat Reitz M, Lanz E. DNA strand breaks in cells with DNA repair deficiency after halothane exposure in vitro. Arzneimittelforschung. 1993;43:418–20.PubMed Reitz M, Lanz E. DNA strand breaks in cells with DNA repair deficiency after halothane exposure in vitro. Arzneimittelforschung. 1993;43:418–20.PubMed
7.
Zurück zum Zitat Karabiyik L, Sardaş S, Polat U, Kocabas NA, Karakaya AE. Comparison of genotoxicity of sevoflurane and isoflurane in human lymphocytes studied in vivo using the comet assay. Mutat Res. 2001;492:99–107.PubMedCrossRef Karabiyik L, Sardaş S, Polat U, Kocabas NA, Karakaya AE. Comparison of genotoxicity of sevoflurane and isoflurane in human lymphocytes studied in vivo using the comet assay. Mutat Res. 2001;492:99–107.PubMedCrossRef
8.
Zurück zum Zitat Shrestha GS, Sah RP, Amatya AG, Shrestha N. Anaesthetic management of patients with xeroderma pigmentosum. A series of three cases. Nepal Med Coll J. 2011;13:231–2.PubMed Shrestha GS, Sah RP, Amatya AG, Shrestha N. Anaesthetic management of patients with xeroderma pigmentosum. A series of three cases. Nepal Med Coll J. 2011;13:231–2.PubMed
9.
Zurück zum Zitat Oliveira CR, Elias L, Barros AC, Conceicao DB. Anesthesia in a patient with xeroderma pigmentosum: case report. Rev Bras Anestesiol. 2003;53:46–51.PubMed Oliveira CR, Elias L, Barros AC, Conceicao DB. Anesthesia in a patient with xeroderma pigmentosum: case report. Rev Bras Anestesiol. 2003;53:46–51.PubMed
10.
Zurück zum Zitat Tobias JD. Dexmedetomidine: applications in pediatric critical care and pediatric anesthesiology. Pediatr Crit Care Med. 2007;8:115–31.PubMedCrossRef Tobias JD. Dexmedetomidine: applications in pediatric critical care and pediatric anesthesiology. Pediatr Crit Care Med. 2007;8:115–31.PubMedCrossRef
Metadaten
Titel
Dexmedetomidine and ketamine combination for a patient with xeroderma pigmentosa
verfasst von
Rakhee Goyal
Mubashir Syed Islam
Publikationsdatum
01.06.2015
Verlag
Springer Japan
Erschienen in
Journal of Anesthesia / Ausgabe 3/2015
Print ISSN: 0913-8668
Elektronische ISSN: 1438-8359
DOI
https://doi.org/10.1007/s00540-014-1928-1

Weitere Artikel der Ausgabe 3/2015

Journal of Anesthesia 3/2015 Zur Ausgabe

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.